非手术非小细胞肺癌的大分割放射治疗被引量：11

Hypofractionated Radiotherapy for Non-surgical Non Small Cell Lung Cancer

导出

摘要非小细胞肺癌约占原发肺癌的85%,对于不可手术或拒绝手术的非小细胞肺癌患者,放射治疗成为治疗的主要手段。随着影像和放疗技术的发展,大分割放疗在非小细胞肺癌中的应用取得了较好的疗效。本文旨在对非小细胞肺癌大分割放疗的放射生物学基础和非手术非小细胞肺癌大分割放疗的最新临床研究进行系统性回顾。 Non small cell lung cancer （NSCLC） accounts for 85% of primary lung cancer. For patients with inoperable or refused surgical NSCLC, radiotherapy has become the main therapeutic method. With the development of radiotherapy technology, hypofractionated radiotherapy has achieved good curative effect in NSCLC. This article aims to systematically review the basis of radiobiology and the latest clinical researches of non-surgical NSCLC treated by hypofraetionated radiotherapy.

作者李四凤(综述) 张鹏郎锦义(审校)

机构地区西南医科大学四川省肿瘤医院·研究所

出处《肿瘤预防与治疗》 2017年第3期208-212,共5页 Journal of Cancer Control And Treatment

基金四川省科技厅支撑项目(编号:No2015SZ0053,No2014SZ0148)

关键词非小细胞肺癌大分割放疗放射生物学临床研究 Non small cell lung cancer Hypofractionated radiotherapy Radiobiology Clinical research

分类号 R737.9 [医药卫生—肿瘤]

引文网络
相关文献

参考文献2

1吕家华,李涛,李昉,王奇峰,刘丽,李厨荣,宋宴琼.图像引导大分割调强放疗同步化疗治疗局部晚期非小细胞肺癌的临床研究[J].肿瘤预防与治疗,2015,28(3):113-116. 被引量：8
2李小明,牛德森.不同放疗分割方式治疗上腔静脉综合症疗效观察[J].疾病监测与控制,2015,9(11):779-780. 被引量：2

二级参考文献19

1于金明,袁双虎.图像引导放射治疗研究及其发展[J].中华肿瘤杂志,2006,28(2):81-83. 被引量：100
2Jemal A, Bray F, Center MM, et al. Global cancer statistics[ J]. CA Cancer J Clin,2011,61 (2) :69 -90.
3Curran WJ, Paulus R, Langer C J, et al. Sequential vs. concur- rent chemoradiation for stage III non-small cell lung cancer: ran- domized phase III trial RTOG 9410 [ J ]. J Natl Cancer Inst,2011, 103 (19) : 1452 - 1460.
4Kepka L, Tyc-Szczepaniak D, Bujko K. Dose-per-fraction escala- tion of accelerated hypofractionated three-dimensional conformal radiotherapy in locally advanced non-small cell lung cancer[J]. J Thorac Oncol,2009,4 (7) :853 - 861.
5Nguyen NP, Bishop M, Borok TJ, et al. Pattern of failure follow- ing chemoradiation for locally advanced non-small cell lung canc- er: potential role for stereotactic body radiotherapy[ J]. Anticancer Res,2010,30 (3) :953 - 961.
6Kong FM, Ten HR, Schipper M J, et al. High-dose radiation ira-proved local tumor control and overall survival in patients with in- operable/unresectable non-small-cell lung cancer: long-term re- suits of a radiation dose escalation study [ J ]. Int J Radiat Oncol Biol Phys ,2005,63 ( 2 ) :324 - 333.
7Kong FM, Ten HR, Schipper M J, et al. An intergroup random- ized phase IlI comparison of standard-dose (60Gy) vs high-dose (74Gy) chemoradiotherapy (CRT) +/- cetuximab (cetux) for stage III non-small cell lung cancer ( NSCLC ) : results on cetux from RTOG 0617 [ J ]. Clin Adv Hematol Oncol,2014,12 ( 1 Suppl 1) :2 -4.
8Bearz A, Miuatel E, Rumeileh IA, et al. Concurrent chemoradio- therapy with tomotherapy in locally advanced non-small cell lung cancer: a phase I, docetaxel dose-esealation study, with hypofrac- tionated radiation regimen[ J]. BMC Cancer,2013,13:513.
9Lin Q, Liu YE, Ren XC, et al. Dose escalation of accelerated hy- pofraetionated three-dimensional eonformal radiotherapy ( at 3 Gy/ fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial [ J ]. Radiat Oncol,2013,8 ( 1 ) :20l.
10Nakamura M, Koizumi T, Hayasaka M, et al. Cisplatin and week- ly docetaxel with concurrent thoracic radiotherapy for locally ad- vanced stage III non-small-cell lung cancer[J]. Cancer Chemother Pharmacol,2009,63(6) :1091 - 1096.